Dermovate

Medicinal product

(Invented) name

Dermovate

Active substance (s)

Klobetazolio propionatas

Strength

500 µg/g

Pharmaceutical form

kremas

Route (s) of administration

vartoti ant odos

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

D07AD01, Clobetasol

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited, Airija

Date of authorisation

1994-03-31

Date of renewal

2007-01-30

Documents

0647 Dermovate kremas II PL 2022 06 30.docx

0647 Pakuotės lapelis kremas 2022 06 30.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 g kremo yra	1 g
Klobetazolio propionatas	500 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
3911	2982	1002982	tūbelė	25 g, N1		Receptinis	LT/1/94/0647/002	Tiekiama	2025-03-27	-	No	-	-	Download

Stadijos

Data	Stadija
2007-01-30	Perregistruotas
1994-03-31	Registruotas